Aspirin vs clopidogrel after TAVR valve procedure
Part of Heart & circulation clinical trials.
This trial compares aspirin and clopidogrel (two blood-thinning medicines) after TAVR to see which is safer or more effective for preventing clots. You may be able to join if you recently had a TAVR for severe aortic valve narrowing and can follow the study plan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 19 years
- You had a TAVR procedure for symptomatic severe aortic stenosis (valve narrowing)
- You can sign a consent form to join the study
- You should not need two blood thinners for longer than 4 weeks
- You should not have had a stroke or TIA (mini-stroke) in the last 6 months
- You must not have major reasons to avoid aspirin or clopidogrel
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking an angiotensin receptor blocker (a type of blood pressure pill) after TAVR helps the heart muscle recover in people with aortic stenosis and thickened heart walls. It's for patients who already had TAVR within the past month and meet safety criteria.
This trial compares two approaches for replacing a tight aortic heart valve (TAVI) through a leg artery: doing it with or without a routine check of your heart's arteries (coronary angiogram). If you have severe aortic stenosis and are scheduled for TAVI, this study helps find out whether skipping the artery check is safe and effective.
This trial tests whether taking aspirin alone is as safe and effective as taking aspirin with warfarin after a TAVR procedure for severe aortic regurgitation. It is for people who do not need long-term blood thinners for other conditions.
This trial compares two blood thinners (ticagrelor and aspirin) to see which one works better at preventing blood clots after a less-invasive heart valve replacement (TAVI). It is for people with severe aortic stenosis who also have diabetes, heart disease, or artery disease.
This trial is for people who have had a TAVI procedure to replace a narrowed heart valve, and it tests whether it is safe to skip blood thinners afterward. The goal is to find the best way to protect your health without unnecessary medication.
This trial compares a short course versus a longer course of antiplatelet medicine (blood thinners) after a TAVI procedure for aortic stenosis. It aims to see which approach is safer and more effective.
Hear when a new Severe Aortic Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.